The adenovirus EIIA enhancer: analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection

MR Loeken, J Brady - Journal of Biological Chemistry, 1989 - Elsevier
MR Loeken, J Brady
Journal of Biological Chemistry, 1989Elsevier
Adenovirus EIIA upstream sequences which contain the binding sites for proteins ATF and
EIIF act as an enhancer and can be trans-activated by both E1A and SV40 T/t-antigens.
Specific mutation of either the ATF or EIIF binding site demonstrates that both act as positive
regulators, decreasing transcription greater than 10-fold. Mutation of both the ATF and EIIF
binding sites inhibited the EIIA enhancer 200-fold. Analysis of insertion mutations suggests
that the spatial alignment of the upstream ATF and EIIF binding sites with respect to the …
Adenovirus EIIA upstream sequences which contain the binding sites for proteins ATF and EIIF act as an enhancer and can be trans-activated by both E1A and SV40 T/t-antigens. Specific mutation of either the ATF or EIIF binding site demonstrates that both act as positive regulators, decreasing transcription greater than 10-fold. Mutation of both the ATF and EIIF binding sites inhibited the EIIA enhancer 200-fold. Analysis of insertion mutations suggests that the spatial alignment of the upstream ATF and EIIF binding sites with respect to the downstream EIIF binding site on the DNA helix is important. Consistent with previous findings, using gel shift analysis we demonstrate that the binding activity of EIIF is increased following wild-type adenovirus infection. In contrast, using identical gel shift conditions, the binding activity of ATF is decreased by viral infection.
Elsevier